282 related articles for article (PubMed ID: 14705986)
1. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood.
Gómez J; Borràs FE; Singh R; Rajananthanan P; English N; Knight SC; Navarrete CV
Tissue Antigens; 2004 Feb; 63(2):149-57. PubMed ID: 14705986
[TBL] [Abstract][Full Text] [Related]
2. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics.
Strobl H; Scheinecker C; Riedl E; Csmarits B; Bello-Fernandez C; Pickl WF; Majdic O; Knapp W
J Immunol; 1998 Jul; 161(2):740-8. PubMed ID: 9670950
[TBL] [Abstract][Full Text] [Related]
4. Early activation markers of human peripheral dendritic cells.
Hellman P; Eriksson H
Hum Immunol; 2007 May; 68(5):324-33. PubMed ID: 17462499
[TBL] [Abstract][Full Text] [Related]
5. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells.
Radvanyi LG; Banerjee A; Weir M; Messner H
Scand J Immunol; 1999 Nov; 50(5):499-509. PubMed ID: 10564553
[TBL] [Abstract][Full Text] [Related]
6. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
Nijman HW; Kleijmeer MJ; Ossevoort MA; Oorschot VM; Vierboom MP; van de Keur M; Kenemans P; Kast WM; Geuze HJ; Melief CJ
J Exp Med; 1995 Jul; 182(1):163-74. PubMed ID: 7790816
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation.
Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK
J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882
[TBL] [Abstract][Full Text] [Related]
8. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
9. Accessory molecules for MHC class II peptide loading.
Busch R; Doebele RC; Patil NS; Pashine A; Mellins ED
Curr Opin Immunol; 2000 Feb; 12(1):99-106. PubMed ID: 10679402
[TBL] [Abstract][Full Text] [Related]
10. CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion?
Comeau MR; Van der Vuurst de Vries AR; Maliszewski CR; Galibert L
J Immunol; 2002 Jul; 169(1):75-83. PubMed ID: 12077231
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP
Anczurowski M; Yamashita Y; Nakatsugawa M; Ochi T; Kagoya Y; Guo T; Wang CH; Rahman MA; Saso K; Butler MO; Hirano N
Sci Rep; 2018 Mar; 8(1):4804. PubMed ID: 29555965
[TBL] [Abstract][Full Text] [Related]
12. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
13. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in human blood dendritic cell subpopulations.
Teig N; Moses D; Gieseler S; Schauer U
Scand J Immunol; 2002 May; 55(5):453-7. PubMed ID: 11975756
[TBL] [Abstract][Full Text] [Related]
15. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
16. What to do with HLA-DO/H-2O two decades later?
Welsh R; Song N; Sadegh-Nasseri S
Immunogenetics; 2019 Mar; 71(3):189-196. PubMed ID: 30683973
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation by HLA-DO of MHC class II-restricted antigen processing.
Denzin LK; Sant'Angelo DB; Hammond C; Surman MJ; Cresswell P
Science; 1997 Oct; 278(5335):106-9. PubMed ID: 9311912
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
Castellaneta A; Abe M; Morelli AE; Thomson AW
Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
[TBL] [Abstract][Full Text] [Related]
19. Novel mutants define genes required for the expression of human histocompatibility leukocyte antigen DM: evidence for loci on human chromosome 6p.
Fling SP; Rak J; Muczynski KA; Arp B; Pious D
J Exp Med; 1997 Nov; 186(9):1469-80. PubMed ID: 9348304
[TBL] [Abstract][Full Text] [Related]
20. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]